Treatment of mice with Activator III reduced the infarction volume, while the SIRT1 and SIRT2 inhibitor sirtinol increased ischemic damage both in the model of ischemic stroke [82] and in the model of hemorrhagic stroke [159]. This evidence concerns the gene SIRT2 and ischemic stroke.